Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Antares and Uman sign RA drug delivery deal
June 2010
SHARING OPTIONS:

EWING, N.J.Antares Pharma Inc., a developer of self-injection drug delivery technology, and Uman Pharma, a manufacturer of injectable pharmaceutical products based in Quebec, Canada, recently announced they will jointly develop and commercialize Antares' Vibex MTX, a pressure-assisted injection device for the delivery of the rheumatoid arthritis (RA) drug methotrexate, for RA and related autoimmune conditions in the United States and Canada. Antares will lead the clinical development program and U.S. Food and Drug Administration (FDA) regulatory submissions, and retains rights to commercialize the product outside of Canada. Uman will perform formulation development and manufacturing activities to support the registration of Vibex MTX and supply methotrexate in prefilled syringes to Antares for the U.S. market. Uman received an exclusive license to commercialize Vibex MTX in Canada. The companies intend to work together to commercialize the product in other territories.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.